|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.92 MXN | -1.04% |
|
-1.97% | -20.73% |
| Capitalization | 19.43B 1.04B 892M 830M 773M 1.42B 89.04B 1.59B 10.05B 3.8B 41.65B 3.88B 3.8B 154B | P/E ratio 2025 * |
8.41x | P/E ratio 2026 * | 7.56x |
|---|---|---|---|---|---|
| Enterprise value | 22.99B 1.22B 1.05B 982M 915M 1.68B 105B 1.88B 11.89B 4.5B 49.27B 4.59B 4.5B 182B | EV / Sales 2025 * |
1.18x | EV / Sales 2026 * | 1.1x |
| Free-Float |
66.05% | Yield 2025 * |
2.01% | Yield 2026 * | 2.11% |
More valuation ratios
* Estimated data
More news
Last Transcript: Genomma Lab Internacional, S.A.B. de C.V.
More press releases
More news
| 1 day | -1.04% | ||
| 1 week | -1.97% | ||
| Current month | -2.78% | ||
| 1 month | -3.68% | ||
| 3 months | -13.05% | ||
| 6 months | -24.46% | ||
| Current year | -20.73% |
| 1 week | 19.75 |  | 20.57 |
| 1 month | 19.75 | | 21.6 |
| Current year | 19.75 | | 29.18 |
| 1 year | 16.98 | | 29.18 |
| 3 years | 12.39 | | 29.18 |
| 5 years | 12.39 | | 29.18 |
| 10 years | 9.9 | | 29.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marco Sparvieri
CEO | Chief Executive Officer | - | 12/04/2023 |
| Director of Finance/CFO | - | 01/12/2015 | |
| Human Resources Officer | - | 01/09/2007 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 30/10/1996 | |
Juan Alonso
BRD | Director/Board Member | - | 06/07/2010 |
| Director/Board Member | - | - |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 0.04% | 32 M€ | +13.76% | - | |
| 0.01% | 89 M€ | -1.19% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.04% | -1.97% | +7.85% | +2.00% | 1.04B | ||
| -3.45% | -0.76% | -18.80% | +132.74% | 718B | ||
| -1.05% | -0.40% | +3.97% | -12.94% | 377B | ||
| -1.84% | -1.78% | +10.93% | +21.33% | 338B | ||
| -2.29% | -3.74% | -55.50% | +3.48% | 308B | ||
| -1.05% | -0.82% | +0.08% | -21.22% | 259B | ||
| -0.38% | -1.59% | -4.00% | +18.56% | 237B | ||
| -1.56% | +2.72% | -14.39% | -2.60% | 222B | ||
| -2.57% | +0.18% | -36.37% | -14.15% | 210B | ||
| -1.52% | -1.51% | -11.40% | +17.62% | 160B | ||
| Average | -1.63% | +0.81% | -11.76% | +14.48% | 283.1B | |
| Weighted average by Cap. | -1.88% | +1.55% | -13.77% | +34.20% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 19.47B 1.04B 893M 831M 775M 1.42B 89.22B 1.59B 10.07B 3.81B 41.73B 3.89B 3.81B 154B | 20.72B 1.1B 951M 885M 824M 1.52B 94.96B 1.69B 10.72B 4.06B 44.42B 4.14B 4.06B 164B |
| Net income | 2.39B 127M 109M 102M 94.91M 174M 10.93B 195M 1.23B 467M 5.11B 477M 467M 18.93B | 2.66B 142M 122M 114M 106M 194M 12.18B 217M 1.38B 520M 5.7B 531M 520M 21.1B |
| Net Debt | 3.56B 189M 163M 152M 141M 260M 16.29B 291M 1.84B 696M 7.62B 711M 696M 28.21B | 3.31B 176M 152M 141M 132M 242M 15.17B 271M 1.71B 648M 7.1B 662M 648M 26.27B |
More financial data
* Estimated data
Employees
1,624
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/07/25 | 19.92 $ | -1.04% | 3,520,739 |
| 11/07/25 | 20.13 $ | +0.60% | 2,418,393 |
| 10/07/25 | 20.01 $ | +0.35% | 2,996,857 |
| 09/07/25 | 19.94 $ | -2.83% | 6,806,840 |
| 08/07/25 | 20.52 $ | +0.98% | 3,461,459 |
End-of-day quote Mexican S.E., July 14, 2025
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
19.92MXN
Average target price
30.25MXN
Spread / Average Target
+51.86%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- LAB B Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition